Anuradha Jayaram

1.6k total citations
24 papers, 427 citations indexed

About

Anuradha Jayaram is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anuradha Jayaram has authored 24 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anuradha Jayaram's work include Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Genomics and Diagnostics (8 papers). Anuradha Jayaram is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Genomics and Diagnostics (8 papers). Anuradha Jayaram collaborates with scholars based in United Kingdom, Italy and United States. Anuradha Jayaram's co-authors include Gerhardt Attard, Daniel Wetterskog, Vincenza Conteduca, Enrique González‐Billalabeitia, Howard I. Scher, Nicole A. Schreiber, Ryon P. Graf, Eric Winquist, Martin Fleisher and Ryan Dittamore and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Anuradha Jayaram

23 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anuradha Jayaram United Kingdom 7 332 263 128 108 69 24 427
Maritza N. Taylor United States 6 313 0.9× 186 0.7× 120 0.9× 117 1.1× 65 0.9× 10 414
Mai N. Van Netherlands 7 259 0.8× 182 0.7× 88 0.7× 165 1.5× 68 1.0× 13 361
Ruth Riisnaes United Kingdom 5 299 0.9× 231 0.9× 90 0.7× 201 1.9× 57 0.8× 5 431
Justin Wahl United States 3 361 1.1× 261 1.0× 133 1.0× 181 1.7× 58 0.8× 4 484
Takayuki Sumiyoshi Japan 11 247 0.7× 145 0.6× 124 1.0× 90 0.8× 30 0.4× 41 351
Robynne Ashe United States 5 293 0.9× 165 0.6× 133 1.0× 56 0.5× 47 0.7× 8 330
George Seed United Kingdom 8 289 0.9× 241 0.9× 112 0.9× 206 1.9× 32 0.5× 21 422
F.P. Fonseca Brazil 7 417 1.3× 230 0.9× 285 2.2× 117 1.1× 30 0.4× 11 559
Sue Merson United Kingdom 5 292 0.9× 190 0.7× 250 2.0× 59 0.5× 28 0.4× 5 431
Rachel Schaefer United States 8 299 0.9× 137 0.5× 115 0.9× 88 0.8× 33 0.5× 14 382

Countries citing papers authored by Anuradha Jayaram

Since Specialization
Citations

This map shows the geographic impact of Anuradha Jayaram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuradha Jayaram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuradha Jayaram more than expected).

Fields of papers citing papers by Anuradha Jayaram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuradha Jayaram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuradha Jayaram. The network helps show where Anuradha Jayaram may publish in the future.

Co-authorship network of co-authors of Anuradha Jayaram

This figure shows the co-authorship network connecting the top 25 collaborators of Anuradha Jayaram. A scholar is included among the top collaborators of Anuradha Jayaram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuradha Jayaram. Anuradha Jayaram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayaram, Anuradha, Nicholas A. Zorko, Kevin Zarrabi, et al.. (2026). A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 96(1). 5–5.
2.
Linch, Mark, Gianmarco Leone, Yien Ning Sophia Wong, et al.. (2024). Nivolumab and ipilimumab for metastatic prostate cancer with an immunogenic signature: The NEPTUNES multi-centre two-cohort, biomarker-selected phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). 5013–5013. 5 indexed citations
4.
Jayaram, Anuradha, Anna Wingate, Daniel Wetterskog, et al.. (2021). Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. Annals of Oncology. 32(6). 726–735. 36 indexed citations
5.
Conteduca, Vincenza, Daniel Wetterskog, Elena Castro, et al.. (2021). Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study. European Journal of Cancer. 152. 49–59. 4 indexed citations
6.
Conteduca, Vincenza, Daniel Wetterskog, Emanuela Scarpi, et al.. (2020). Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer. British Journal of Cancer. 123(6). 982–987. 27 indexed citations
7.
Wu, Anjui, Paolo Cremaschi, Daniel Wetterskog, et al.. (2020). Genome-wide plasma DNA methylation features of metastatic prostate cancer. Journal of Clinical Investigation. 130(4). 1991–2000. 64 indexed citations
8.
Kleftogiannis, Dimitrios, Marco Punta, Anuradha Jayaram, et al.. (2019). Identification of single nucleotide variants using position-specific error estimation in deep sequencing data. BMC Medical Genomics. 12(1). 115–115. 7 indexed citations
9.
Cottu, Paul, Anuradha Jayaram, Antoîne Italiano, et al.. (2019). Pooled analysis of onapristone extended release (ONA ER) in metastatic cancer patients (pts): A review of liver safety.. Journal of Clinical Oncology. 37(15_suppl). e14647–e14647. 1 indexed citations
10.
González‐Billalabeitia, Enrique, Vincenza Conteduca, Daniel Wetterskog, Anuradha Jayaram, & Gerhardt Attard. (2018). Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test. Prostate Cancer and Prostatic Diseases. 22(2). 195–205. 44 indexed citations
11.
Conteduca, Vincenza, Anuradha Jayaram, Nuria Romero-Laorden, et al.. (2018). Plasma androgen receptor (pAR) status and activity of taxanes in metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(15_suppl). 5074–5074. 2 indexed citations
12.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2018). Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer. JAMA Oncology. 4(9). 1179–1179. 160 indexed citations
14.
Rescigno, Pasquale, David Lorente, Diletta Bianchini, et al.. (2016). Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. European Urology. 70(5). 724–731. 52 indexed citations
15.
Zafeiriou, Zafeiris, Anuradha Jayaram, Adam Sharp, & Johann S. de Bono. (2016). Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents. Drugs. 76(4). 421–430. 4 indexed citations
16.
Kolinsky, Michael, Joaquı́n Mateo, Semini Sumanasuriya, et al.. (2016). Clinical characteristics of metastatic castration-resistant prostate cancer (mCRPC) patients with DNA repair (DNAr) defects.. Journal of Clinical Oncology. 34(15_suppl). 5028–5028. 2 indexed citations
17.
Jayaram, Anuradha & Gerhardt Attard. (2015). Cabazitaxel—a key therapeutic option in prostate cancer. Nature Reviews Urology. 12(6). 312–313. 4 indexed citations
19.
Rescigno, Pasquale, David Lorente, Roberta Ferraldeschi, et al.. (2015). Association between PSA declines at 4 weeks and OS in patients treated with abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC) after docetaxel.. Journal of Clinical Oncology. 33(7_suppl). 215–215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026